Literature DB >> 974261

Abnormal hemoglobins in a quarter million people.

R G Schneider, B Hightower, T S Hosty, H Ryder, G Tomlin, R Atkins, B Brimhall, R T Jones.   

Abstract

Hemolysates of erythrocytes from more than a quarter million people in Alabama were electrophoresed on cellulose acetate, pH 8.4, and those samples exhibiting an abnormality were also electrophoresed in citrate agar, pH 6.0. The globin chains of mutants other than Hb S and C were electrophoresed in urea-mercaptoethanol buffers at both pH 8.9 and pH 6.0, and 60 of them were also analyzed structurally. Of about 6000 samples from whites, only three contained abnormal hemoglobins--Hb D Los Angeles, Hb J Baltimore, and one unidentified. Of 249,000 samples from blacks, about 29,000 contained electrophoretically detectable abnormalities, most of them associated with Hb S or C, present in a frequency of about 9% and 3%, respectively. About 1000 samples resolved into patterns of potential clinical significance. Twenty other mutant hemoglobins were detected, in various genetic combinations in 164 kindreds; four of these-Hb Alabama, Montgomery, Titusville, and Mobile--were previously unknown. The methods used are rapid, economical, and well suited for large scale surveys. They provide highly specific characterizations of many mutant hemoglobins, and no discrepancies were found between the presumptive identifications based on these characterizations and the definitive identifications obtained from structural analyses.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974261

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Fetal hemoglobin variants in 80,000 Japanese neonates: high prevalence of Hb F Yamaguchi (A gamma T 80 Asp----Asn).

Authors:  Y Wada; T Fujita; K Kidoguchi; A Hayashi
Journal:  Hum Genet       Date:  1986-03       Impact factor: 4.132

2.  High prevalence of sickle cell trait in African Americans with ESRD.

Authors:  Vimal K Derebail; Patrick H Nachman; Nigel S Key; Heather Ansede; Ronald J Falk; Abhijit V Kshirsagar
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

3.  Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose.

Authors:  Vimal K Derebail; Eduardo K Lacson; Abhijit V Kshirsagar; Nigel S Key; Susan L Hogan; Raymond M Hakim; Ann Mooney; Chinu M Jani; Curtis Johnson; Yichun Hu; Ronald J Falk; J Michael Lazarus
Journal:  J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 10.121

Review 4.  Rare variants, private polymorphisms, and locus heterozygosity in Amerindian populations.

Authors:  J V Neel
Journal:  Am J Hum Genet       Date:  1978-09       Impact factor: 11.025

5.  The sensitivity of gel electrophoresis as a detector of genetic variation.

Authors:  J A Ramshaw; J A Coyne; R C Lewontin
Journal:  Genetics       Date:  1979-12       Impact factor: 4.562

Review 6.  Sickle-cell trait: novel clinical significance.

Authors:  Nigel S Key; Vimal K Derebail
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

7.  Abnormal haemoglobin variants, ABO and Rh blood groups among student of African descent in Port Harcourt, Nigeria.

Authors:  Zaccheaus Awortu Jeremiah
Journal:  Afr Health Sci       Date:  2006-09       Impact factor: 0.927

8.  Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.

Authors:  Pamela J Hicks; Carl D Langefeld; Lingyi Lu; Anthony J Bleyer; Jasmin Divers; Patrick H Nachman; Vimal K Derebail; Donald W Bowden; Barry I Freedman
Journal:  Kidney Int       Date:  2011-08-17       Impact factor: 10.612

9.  Newborn diagnosis of abnormal hemoglobins from a large municipal hospital in Los Angeles.

Authors:  N Ewing; D Powars; J Hilburn; W A Schroeder
Journal:  Am J Public Health       Date:  1981-06       Impact factor: 9.308

10.  Co-inheritance of sickle cell trait and thalassemia mutations in South central iran.

Authors:  N Saleh-Gohari; M Mohammadi-Anaie
Journal:  Iran J Public Health       Date:  2012-10-01       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.